| 000 | 01472 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516054457.0 | ||
| 264 | 0 | _c20120214 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0024265 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJager, Eva | |
| 245 | 0 | 0 |
_aTargeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization. _h[electronic resource] |
| 260 |
_bPloS one _c2011 |
||
| 300 |
_ae24265 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAminoglycosides _xpharmacokinetics |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xpharmacokinetics |
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 |
_aAntigens, Differentiation, Myelomonocytic _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aGemtuzumab |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xmetabolism |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 | _aSialic Acid Binding Ig-like Lectin 3 |
| 700 | 1 | _avan der Velden, Vincent H J | |
| 700 | 1 | _ate Marvelde, Jeroen G | |
| 700 | 1 | _aWalter, Roland B | |
| 700 | 1 | _aAgur, Zvia | |
| 700 | 1 | _aVainstein, Vladimir | |
| 773 | 0 |
_tPloS one _gvol. 6 _gno. 9 _gp. e24265 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0024265 _zAvailable from publisher's website |
| 999 |
_c21154968 _d21154968 |
||